NCT00520481 2018-07-19Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate CancerEli Lilly and CompanyPhase 2 Completed41 enrolled 14 charts
NCT01120236 2018-02-26Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerNational Cancer Institute (NCI)Phase 2 Completed211 enrolled 17 charts